These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 16155017)

  • 1. Prognostic and therapeutic significance of myeloma genetics and gene expression profiling.
    Stewart AK; Fonseca R
    J Clin Oncol; 2005 Sep; 23(26):6339-44. PubMed ID: 16155017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic significance of cytogenetics and molecular profiling in multiple myeloma.
    Sawyer JR
    Cancer Genet; 2011 Jan; 204(1):3-12. PubMed ID: 21356186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profiling and multiple myeloma.
    Shaughnessy J; Zhan F; Barlogie B; Stewart AK
    Best Pract Res Clin Haematol; 2005; 18(4):537-52. PubMed ID: 16026736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights from the gene expression profiling of multiple myeloma.
    Claudio JO; Masih-Khan E; Stewart AK
    Curr Hematol Rep; 2004 Jan; 3(1):67-73. PubMed ID: 14695854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testing standard and genetic parameters in 220 patients with multiple myeloma with complete data sets: superiority of molecular genetics.
    Shaughnessy JD; Haessler J; van Rhee F; Anaissie E; Pineda-Roman M; Cottler-Fox M; Hollmig K; Zangari M; Mohiuddin A; Alsayed Y; Grazziutti M; Epstein J; Crowley J; Barlogie B
    Br J Haematol; 2007 Jun; 137(6):530-6. PubMed ID: 17489983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of molecular diagnostics in multiple myeloma.
    Stewart AK; Fonseca R
    Expert Rev Mol Diagn; 2007 Jul; 7(4):453-9. PubMed ID: 17620051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetics and molecular profiling of multiple myeloma: novel tools for clinical management?
    Tassone P; Tagliaferri P; Rossi M; Gaspari M; Terracciano R; Venuta S
    Eur J Cancer; 2006 Jul; 42(11):1530-8. PubMed ID: 16820292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetics and molecular cytogenetics in multiple myeloma.
    Liebisch P; Döhner H
    Eur J Cancer; 2006 Jul; 42(11):1520-9. PubMed ID: 16781866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interphase fluorescence in situ hybridization in multiple myeloma and monoclonal gammopathy of undetermined significance without and with positive plasma cell identification: analysis of 192 cases from the Region of Southern Denmark.
    Christensen JH; Abildgaard N; Plesner T; Nibe A; Nielsen O; Sørensen AG; Kerndrup GB;
    Cancer Genet Cytogenet; 2007 Apr; 174(2):89-99. PubMed ID: 17452249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosomal translocations t(4;14), t(11;14) and proliferation rate stratify patients with mature plasma cell myelomas into groups with different survival probabilities: a molecular epidemiologic study on tissue microarrays.
    Tinguely M; Jenni B; Reineke T; Korol D; Kofler A; Rousson V; Dommann-Scherrer C; Maurer R; Moch H; Probst-Hensch NM
    Am J Surg Pathol; 2007 May; 31(5):690-6. PubMed ID: 17460451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profiling in multiple myeloma--reporting of entities, risk, and targets in clinical routine.
    Meissner T; Seckinger A; Rème T; Hielscher T; Möhler T; Neben K; Goldschmidt H; Klein B; Hose D
    Clin Cancer Res; 2011 Dec; 17(23):7240-7. PubMed ID: 21986844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular genetic methods for the prognostic criteria in multiple myeloma].
    Mikala G; Jákó J; Vályi-Nagy I
    Orv Hetil; 2005 Aug; 146(32):1673-82. PubMed ID: 16149245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fluorescence in situ hybridization identifies complex chromosomal aberrations in multiple myeloma].
    Liu SY; Huang JW; Zhang J; Du HP; Jiang H; Li JY; Xue YQ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):685-8. PubMed ID: 18067084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular classification of multiple myeloma: a distinct transcriptional profile characterizes patients expressing CCND1 and negative for 14q32 translocations.
    Agnelli L; Bicciato S; Mattioli M; Fabris S; Intini D; Verdelli D; Baldini L; Morabito F; Callea V; Lombardi L; Neri A
    J Clin Oncol; 2005 Oct; 23(29):7296-306. PubMed ID: 16129847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic abnormalities in chronic lymphocytic leukemia influence gene expression by a gene dosage effect.
    Dickinson JD; Joshi A; Iqbal J; Sanger W; Bierman PJ; Joshi SS
    Int J Mol Med; 2006 May; 17(5):769-78. PubMed ID: 16596259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosome 13q deletion and IgH abnormalities may be both masked by near-tetraploidy in a high proportion of multiple myeloma patients: a combined morphology and I-FISH analysis.
    Koren-Michowitz M; Hardan I; Berghoff J; Yshoev G; Amariglio N; Rechavi G; Nagler A; Trakhtenbrot L
    Cancer Lett; 2007 Oct; 255(2):307-14. PubMed ID: 17590504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic heterogeneity in multiple myeloma.
    Magrangeas F; Lodé L; Wuilleme S; Minvielle S; Avet-Loiseau H
    Leukemia; 2005 Feb; 19(2):191-4. PubMed ID: 15538406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicolor interphase cytogenetics for the study of plasma cell dyscrasias.
    Sáez B; Martín-Subero JI; Odero MD; Prosper F; Cigudosa JC; Schoch R; Calasanz MJ; Siebert R
    Oncol Rep; 2007 Nov; 18(5):1099-106. PubMed ID: 17914559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel chromosomal translocations in multiple myeloma: t(13;16)(q14;q24) and t(1;15)(q10;q26).
    Akalin I; Kutlay NY; Ilhan O; Tukun A
    Int J Lab Hematol; 2007 Jun; 29(3):215-20. PubMed ID: 17474900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetic data as a prognostic factor in multiple myeloma patients: involvement of 1p12 region an adverse prognostic factor.
    Panani AD; Ferti AD; Papaxoinis C; Raptis SA; Roussos Ch
    Anticancer Res; 2004; 24(6):4141-6. PubMed ID: 15736465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.